News

formación continuada de PRIM a profesionales sanitarios

PRIM’s New Educational Platform for Health Professionals: PrimAcademy

PrimAcademy offers certified training to improve the skills of healthcare professionals. The PRIM Group has launched PrimAcademy, an innovative educational platform designed to provide education and training for healthcare professionals,…

PRIM holds its 2024 Annual General Meeting of Shareholders, where it shares with its shareholders the results and key milestones for 2023

During the meeting, held on Friday 28 June, the Group's figures and management for the 2023 financial year were presented, as well as the pillars on which it is based to consolidate profitable and sustainable growth. Main results achieved During…

The Ortega-Marañón Foundation and PRIM sign a collaboration agreement for the implementation of orthoprosthetics training programs

Madrid, May 29th, 2024. The Ortega-Marañón Foundation and PRIM, Establishments Orthopedic Prim S.A. (EOP), have signed a collaboration agreement to develop training programs on orthopedics and prosthetics, which will have the participation…

PRIM earns 51% more in 2023, up to 12.6 million, and raises shareholder payout to 60%

With a 9.8% increase in sales, the Company outperforms the market and gains market share in its leading areas Both the Group's Ebitda and Operating Profit show significant increases of 47% and 71%, respectively The Board of Directors…

Hospital La Paz Neurosurgery Unit being first one using Prim Excelsius GPS Robotic Arm

This new revelation makes the Neurosurgery Service at the Hospital La Paz in Madrid the first public or private hospital in the country to offer the state-of-the-art Excelsius GPS technology for back surgery. To date this equipment has been…

SpineAI: Intelligent Platform for the Treatment and Monitoring of Idiopathic Scoliosis through the use of Artificial Intelligence

On Monday 6 November, the launch meeting of the SpineAI project was held. It took place at the IDONIAL technology centre facilities at the Gijón Science and Technology Park and brought together all the cooperating entities who will work on…

PRIM consolidates the pace of its revenue growth with an almost 9% increase in the first nine months of the year

The Company achieved an 11.2% increase in EBITDA, amounting to an accumulated €17.7 million in the third quarter.   The PRIM Group has strengthened its growth during the first nine months of the year, with an 8.8% increase in…

PRIM joins forces with the HM Hospitals Research Foundation to enhance the early detection of neurodegenerative diseases

  Both institutions have agreed to conduct research in order to corroborate the usefulness of the ocular motility of the Oscann™ device for the early and progressive diagnosis of Alzheimer's and Parkinson's disease. The research…

PRIM and AURA Innovative Robotics Join Forces to Revolutionise the Early Diagnosis of Neurological Diseases

According to data from the Spanish Society of Neurology (SEN), neurological diseases affect more than 7 million people in Spain. Their early diagnosis is essential to improve the prognosis and quality of life for patients and to provide…

PRIM BECOMES A SPONSOR OF THE IDIS FOUNDATION

The Board of Trustees of the Institute for the Development and Integration of Health (the IDIS Foundation) has approved the inclusion of PRIM as a new sponsor, resulting in it becoming one of the 23 entities that make up the IDIS Foundation…

PRIM holds its 2023 Ordinary General Shareholders’ Meeting where innovation and strategic alliances are the main protagonists

The medical technology company saw 17% growth in 2022, which is far beyond the 4% figure seen in the market as a whole It reached €197 million in revenue last year, confirming the success of its 21/25 Strategic Plan The PRIM Group…

PRIM announces that it is joining the United Nations Global Compact

We joined the UN Global Compact, as part of our 2023 ESG Master Plan to incorporate the universal framework of the Ten Principles and SDGs into our organisation's strategy. Launched in the year 2000, the United Nations Global Compact…

PRIM strengthens its growth rate with a 17% improvement in consolidated revenues

The Board of Directors approves a second dividend of €0.11 per share being distributed for the 2022 financial year. The Company has designed a comprehensive ESG Strategic Plan, with an outlook towards 2025 to advance with its implementation…

International Day of Women and Girls in Science

11 February is the International Day of Women and Girls in Science. At PRIM we are proudly part of this mission to inspire and promote the participation of present and future generations of women in Science. We have invited three PRIM…

The PRIM Group drives growth with almost 20% revenue increase

This 2022 financial year is being marked by the organisation’s transformation to meet the objectives of the 2021/2025 Strategic Plan. The PRIM Group achieved strong revenue growth during the first nine months of the year, with turnover…

The Minister of Science and Innovation visits PRIM’s corporate headquarters

Diana Morant has shown a particular interest in Aura, a project that the Prim Group is part of, for the early detection of neurodegenerative diseases On 5 October, the Minister of Science and Innovation, Diana Morant Ripoll, visited PRIM's…

PRIM finalises new acquisitions in Italy and Spain to strengthen its leadership and growth

The investment will enhance the Group's technological capacity and generate significant commercial and operational synergy The Prim Group has finalised the purchase of the Italian company Easytech and the Catalan company Teyder, operations…

PRIM and TRAK: the alliance shaping the future of physiotherapy

PRIM, the leading Spanish health sector company that offers specialist medical services, with an export network of 75 countries, is revolutionising the health market with the introduction of a digital physiotherapy service. This service…

Prim accelerates its growth with 21% revenue growth in the first half of the year

The Company has a solid financial position that has allowed it to make extensive cash investments as well as implement new strategic investments The Prim Group continues to accelerate its growth in the current financial year 2022. During…

PRIM will transform its logistics to make data-driven strategic decisions

PRIM Group will move forward with data-driven strategic decision-making at three of its warehouses in Spain thanks to Mecalux's Easy WMS management software. "Digitalisation is one of the pillars of the PRIM Group's 2021-25 Strategic Plan. It…

PRIM increases recurring sales by 13% with an improvement of more than 18% in its margins

The Prim Group closed the first quarter of this year 2022 with an increase of 13% in its recurring or comparable turnover to the previous year. This revenue does not include the €5 million in sales generated from the companies acquired after…

PRIM finalises the purchase of the Valencia company Laboratorios Herbitas and strengthens its growth strategy

The Prim Group has finalised its purchase of Laboratorios Herbitas, a company from Valencia that has over 30 years of experience in the market and a wide range of products in the orthopaedic, pharmacy and podiatry sectors, a field which…

PRIM commits to increasing its dividends by 60% and launches a new share buyback plan

Prim reiterates its commitment to improving overall shareholder remunerations for the 2021 financial year. At its first Shareholder and Investor Day, held at the new corporate headquarters in Madrid, the chair, Lucía Comenge, set out the general…

PRIM increases net profit by more than 151% during 2021 with growth of more than 14% in sales

The Prim Group has closed the 2021 financial year with notable growth in both profits and turnover. The Company has increased sales by more than 14% to €168.5 million, an amount that is also higher than the figures seen during 2019 (+11.5%),…

PRIM calculates its carbon footprint

PRIM S.A. and Establecimientos Ortopédicos PRIM S.A. (PRIM Establecimientos Ortopédicos) have finished calculating their carbon footprint in line with UNE-ISO 14064:2012, which measures the emission of greenhouse gases associated with the…

PRIM improves its net profit for the first nine months of the year by 90% with an increase in sales of more than 13%

The Prim Group has accelerated its growth of sales, EBITDA and both operating and net profit during the first nine months of the year. This means the Company has surpassed figures recorded in September 2019, prior to the pandemic. The net…

PRIM Group accelerates its growth in the first half of 2021

The Prim Group has closed the first half of 2021 with significant growth across all of the items on its consolidated income statement. Net profit stood at €10.5 million, representing an improvement of nearly 184% compared to the same period…

PRIM will accompany the Spanish Paralympic team at the Tokyo Games

PRIM and the Spanish Paralympic Committee (CPE) have reached an agreement for Prim to be the Official Provider of its medical and physiotherapy services. It will provide state-of-the-art materials and equipment to the more than 139 athletes…
,

PRIM strengthens its Orthopaedics subsidiary branch with the purchase of the specialist clinics Ilunion and Ortoayudas

The Prim Group has completed the purchase of the Orthopaedics branches of the companies Ilunion Salud, which belongs to the Social Once Group, and of Orto Ayudas, a company specialising in electric mobility, seating, positioning and technical…
,

The presence of women on PRIM’s Board of Directors surpasses the CNMV’s parity targets set for 2022

The presence of women on Prim's Board of Directors has risen significantly in recent years, from a percentage of 14% in 2019 to 44% now. This participation means that the Company is among 10 of the listed companies that are surpassing the new…
,

PRIM controls the overall impact of Covid-19 in 2020 and reaches revenues of over €147 million, in line with the previous year

The Prim Group closed the 2020 financial year with a turnover of €147.3 million (-2.43%), very much in line with the €150.9 million seen the previous year and above the revised forecast made as a result of Covid-19, with the pandemic having…
,

PRIM Move-On: our first fully online Annual Sales Meeting

Throughout our 150 years, we have prided ourselves on our ability to adapt to new situations. And this week we have once again proven that by holding our first PRIM Move-On Annual Sales Meeting, which brought together all those people who make…
,

PRIM improves its quarterly net profit by 87% with an increase in sales of more than 10%

The Prim Group recorded a significant improvement in sales, EBITDA and both its operating and net profits during the third quarter of this year, which enabled the company to lessen the negative impact suffered by its business during the first…
,

PRIM concludes its succession plan with the announcement of Fernando Oliveros as the Group’s chief executive

Prim has approved the appointment of Fernando Oliveros as the company’s new Managing Director, who will join the company at the beginning of November. Fernando Oliveros, born in Mexico City in 1971, began his professional career with the…
,

The PRIM Group obtains its Family-Responsible Company certification

En 2020 el Grupo PRIM ha reforzado su compromiso con la conciliación y el desarrollo profesional, personal y social de sus colaboradores/as internos/as, con la obtención del sello efr, que le acredita como Empresa Familiarmente Responsable.
,

PRIM’s net profit reached €3.7 million in the first half of the year, following the impact of Covid-19

The Prim Group closed the first half of 2020 with a net profit of €3.7 million and an EBITDA of over €7.1 million, resulting in downturns of 31.7% and 30.1%, respectively. Every item on the income statement was affected by the pandemic…
,

PRIM improves its operating profit by 8.77% with an increase in sales of close to 10%

The Prim Group closed the first quarter of 2020 with a 9.46% increase in sales, bringing its net turnover to more than €38.3 million compared to €35 million during the same period in the previous year. This growth is the result of, among…
,

PRIM’s Board of Directors approves its succession plan at the top of the company

At its meeting today, the Board of Directors of Prim, S.A. approved a succession plan to renew the Company's leadership. This agreement is the culmination of the Action Plan approved by the Board in its meeting on 30 January 2019, which included…
,

PRIM reaches an agreement with Laboratorios Milo to purchase its Parapharmacy, Orthopaedic and Podiatry ranges.

This operation "strengthens" the Prim group’s presence in the Pharmaceutical sector and enables it to continue to enhance its growth strategy within the healthcare industry thanks to the complementary nature of both companies’ structures…

This post is also available in: Spanish